Revlimid

Clinical Trial For Revlimid To Be Halted!

According to Bloomberg News Celgene Corp. said it will stop a study (Mainsail) of its blood-cancer pill Revlimid as a treatment for prostate cancer because the drug failed to help patients more than chemotherapy and steroids alone. This conclusion was drawn after the data-monitoring panel found the drug did not meet its primary goal of [...]

By |2011-12-01T13:28:33-05:00December 1st, 2011|Advanced Prostate Cancer, Clinical Trials, Clinical Trials, Drugs & Treatments, Uncategorized|0 Comments
Read More

Lenalidomide in Combination with Docetaxel to Treat Advanced Prostate Cancer

More from my explorations at the American Association of Cancer Researchers (AACR) conference in Washington, D.C. Abstract 5386 described a study using a thalidomide analogue called lenalidomide (Revlimid), in combination with Taxotere, which currently is the only approved drug for chemotherapy for advanced, metastatic castrate resistant prostate cancer. […]

By |2010-04-25T23:42:07-04:00April 25th, 2010|Advanced Prostate Cancer, Clinical Trials, Clinical Trials, On The Horizon, Research, thalidomide, Uncategorized, Understanding APC|0 Comments
Read More
Go to Top